CSI Market
Sign In | Register

Apimeds Pharmaceuticals US (APUS) Annual Balance Sheets

Annual · GAAP · USD millions
Access APUS quarterly Balance Sheets →
A period-by-period view of the balance sheet from Apimeds Pharmaceuticals US to helps clarify how Dec 31 2025's financial structure has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2023)
Assets
Cash & cash equivalent1.64
Cash, Cash Equivalents Other9.64
Marketable Securities2.00
Cash & Short-term Investments12.00
Total loans net2.30
Total Current Assets13.98
Equipment/Property/Plant Net0.05
Tax Assets, Noncurrent2.65
Deferred, Prepaid and Other Assets, Noncurrent0.08
Total Assets164.18
Liabilities
Accounts Payable0.92
Accrued Liabilities, Current0.92
Financial Instruments1.62
Short-term Debt7.09
Total Current Liabilities10.71
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.25
Total Liabilities10.84
Stockholders' Equity
Common Stock Value0.13
Additional Paid In Capital Common Stock163.54
Retained Earnings / Accumulated Deficit-10.39
Common Stockholder's Equity153.27
Preferred Stockholder's Equity0.07
Total Stockholder's Equity153.35
Liabilities & Stockholder's Equity164.18
4 historic quarters locked

Sign in to unlock the full Apimeds Pharmaceuticals US balance sheet history.

Sign In Create Free Account

About Apimeds Pharmaceuticals Us Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-051139

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.